temozolomide (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the temozolomide drug offered from Cadila Healthcare Limited. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | temozolomide |
SUBSTANCE NAME: | TEMOZOLOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-26 |
END MARKETING DATE: | 0000-00-00 |
temozolomide HUMAN PRESCRIPTION DRUG Details:
Item Description | temozolomide from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70771-1092_f2ab10a0-5cf1-4073-9512-d6341bb3d40e |
PRODUCT NDC: | 70771-1092 |
APPLICATION NUMBER: | ANDA206750 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers: